• Accuitive Medical Ventures (AMV) and The Innovation Factory (TIF; both Duluth, Georgia) have added Rudy Mazzocchi to both management teams. He will serve as a venture partner with AMV and as vice president, business development with TIF. Mazzocchi most recently served as chairman and Interim-CEO of Triton BioSystems. Previously, he was co-founder and CEO of Image-Guided Neurologics. The Innovation Factory, a medical device-focused venture, was created in 1999 and has spun out several device companies, including Acufocus, LipoSonix, Neuronetics, and NeoVista. Accuitive Medical Ventures.

• Dade Behring Holdings (Deerfield, Illinois) said Donal Quinn has been appointed to the newly created position of chief operating officer, and Mark Wolsey-Paige has been appointed to the newly created position of chief strategy and technology officer. Hiroshi Uchida, president, global operations and supply chain has resigned from the company to join another firm. Quinn joined Dade Behring in 1998 and has served as the company’s president, global customer management since 2002. For the last four years, Wolsey-Paige has managed the company’s research and development and strategic planning functions. He joined Baxter Diagnostics, the company’s predecessor, in 1991. Quinn and Wolsey-Paige’s newly appointed roles will become effective Jan 1. Dade Behring offers products and services for laboratories.

Anthony Kesman has been appointed an operating partner at Linden (Chicago), a private investment firm that focuses on middle market leveraged buyout investments in the healthcare and life sciences sector. Previously Kesman was with Allegiance Healthcare, a subsidiary of Cardinal Health.